VYNE
VYNE Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
VYNE Therapeutics (VYNE) Stock: Buy, Sell, or Hold?
$28.56
+28.05 (+5511.00%)
â˛
5d:
+3435.53%
30d:
+4282.38%
90d:
+4327.22%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (76%)
Quality Score
39/100
Position
FAIR
Forward P/E & Valuation
-0.4x
Next 12M consensus est.
Wall Street Target
$2.00
-93.0% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.47 / $28.56
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: VYNE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When VYNE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VYNE is currently trading at $28.56, which is considered fair based on recent price action.
Technical Outlook: Technically, VYNE is in a strong downtrend. The price is approaching resistance at $28.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5511.0% recently.
Market Sentiment: VYNE scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VYNE is in a strong downtrend. The price is approaching resistance at $28.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5511.0% recently.
Market Sentiment: VYNE scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
39/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
Trading Range & Key Levels
Support Level
$0.47
Resistance Level
$28.56
Current Trend
Strong Downtrend
Technical data as of
Jul 27, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+5511.0%)
- BEARISH: Trading 93.0% above Wall St target ($2.00)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.35
Wall Street Target
$2.00
(-93.0%)
Revenue Growth (YoY)
-57.4%
Share VYNE Analysis
Share this live VYNE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VYNE)
Bearish
4 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Jul 18, 2026
Daily AI digest
AI Retail Discussion Summary:
Two bullish StockTwits messages suggest optimism around insider buying and upcoming voting results for $VYNE.
Key Retail Themes:
Insider buying
Upcoming voting results
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:23 AM ET
Data refreshes hourly during market hours. Next update: 6:23 AM
Data refreshes hourly during market hours. Next update: 6:23 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VYNE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VYNE Research Pages
